# FDA 483 - Richard F. McGuire, Jr., MD - August 06, 2021

Source: https://www.keypedia.com/records/483/richard-f-mcguire-jr-md/0ac3261d-826e-4d52-ad15-9813cdbf910a

> FDA 483 for Richard F. McGuire, Jr., MD on August 06, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Richard F. McGuire, Jr., MD
- Inspection Date: 2021-08-06
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: The FDA inspected Richard F. McGuire, Jr., MD, a clinical investigator in La Mirada, CA, from August 2-6, 2021. The inspection revealed a severe lack of routine oversight by the Principal Investigator during clinical studies, leading to widespread falsification of study documents. Specifically, the Study Coordinator made fraudulent signatures on behalf of the investigator and performed duties for which they were not qualified, such as reviewing ECG tracings and conducting physical exams.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)

Company: https://www.keypedia.com/companies/richard-f-mcguire-jr-md/0c1692bc-4eef-4c89-84f7-63d22db34bd6

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6